{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:11:15Z","timestamp":1761109875426},"reference-count":25,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T00:00:00Z","timestamp":1208304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycoses"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>To study and establish an optimal administration method of oral antifungal, terbinafine (TBF), for hyperkeratotic\u2010type tinea pedis from the pharmacokinetic point of view, 20 patients with hyperkeratotic\u2010type tinea pedis were given TBF 125\u2003mg once daily for 4\u2003weeks and observed over time for improvement of dermatological symptoms and mycological efficacy. Targeting five of the patients, TBF concentration in the stratum corneum was measured using the LC\u2010MS\/MS method. TBF was detected in the stratum corneum of the sole 1\u2003week after beginning the treatment in some cases and reached its peak 1\u2003week after the completion of the treatment with a concentration of 247.8\u2003ng\u2003g<jats:sup>\u22121<\/jats:sup>, which was approximately more than 50 times higher than its minimal inhibitory concentration against dermatophytes. TBF was not detected at 8\u2003weeks post\u2010treatment, although its concentration was 50.73\u2003ng\u2003g<jats:sup>\u22121<\/jats:sup> at 6\u2003weeks post\u2010treatment. All cases were subjected to analysis for final total efficacy, general safety and usefulness. Its effectiveness rate (effective\u2003+\u2003markedly effective) was 95% (19\/20) with no adverse reactions, including abnormal changes in the laboratory test values, in any patients. From the above, it is noted that TBF showed excellent efficacy and safety for refractory hyperkeratotic\u2010type tinea pedis, and also it was considered as a useful drug to treat cutaneous mycosis, including hyperkeratotic\u2010type tinea pedis, from the pharmacokinetic point of view.<\/jats:p>","DOI":"10.1111\/j.1439-0507.2008.01509.x","type":"journal-article","created":{"date-parts":[[2008,4,17]],"date-time":"2008-04-17T06:46:52Z","timestamp":1208414812000},"page":"523-531","source":"Crossref","is-referenced-by-count":3,"title":["Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic\u2010type tinea pedis"],"prefix":"10.1111","volume":"51","author":[{"given":"Izumi","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,8]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1997.tb00219.x"},{"key":"e_1_2_6_3_2","first-page":"484","article-title":"Topical treatment of refractory dermatomycosis, hyperkeratotic tinea pedis","volume":"10","author":"Tanuma H","year":"1995","journal-title":"Jpn J Dermatol"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0933-7407.2001.00607.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00403.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1989.tb00906.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.56.844"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1998.tb00317.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.2000.00578.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2003.00952.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2000.00560.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1992.tb00001.x"},{"key":"e_1_2_6_13_2","first-page":"1365","article-title":"Activity of terbinafine in experimental fungal infections of laboratory animals","volume":"31","author":"Pentranyi G","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639209088693"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1998.00402.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1991.tb14752.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70294-R"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70293-Q"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.2336\/nishinihonhifu.56.374"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1995.tb00037.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546639009089035"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.3314\/jjmm.43.79"},{"key":"e_1_2_6_23_2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2340\/0001555571322326","article-title":"Terbinafine levels in serum, stratum corneum, dermis\u2010epidermis (without stratum corneum), hair, sebum and eccrine sweat","volume":"71","author":"Faergemann J","year":"1991","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01138.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","article-title":"Levels of terbinafine in plasma, stratum corneum, dermis\u2010epidermis (without stratum corneum), sebum, hair, and nails during and after 250\u2003mg terbinafine orally once per day for four weeks","volume":"73","author":"Faergemann J","year":"1993","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81838-5"}],"container-title":["Mycoses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1439-0507.2008.01509.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1439-0507.2008.01509.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T03:52:03Z","timestamp":1696909923000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1439-0507.2008.01509.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,8]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1439-0507.2008.01509.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1439-0507.2008.01509.x","archive":["Portico"],"relation":{},"ISSN":["0933-7407","1439-0507"],"issn-type":[{"value":"0933-7407","type":"print"},{"value":"1439-0507","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,8]]}}}